Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease

Journal of Virology

Volumn 71, Issue 1, 1997, Pages 663-677

  Ganeshan, Shanthi ^a   Dickover, Ruth E ^b   Korber, Bette T M ^c   Bryson, Yvonne J ^b   Wolinsky, Steven M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; NEVIRAPINE; VIRUS DNA; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DOUBLE BLIND PROCEDURE; ENVELOPE GENE; FEMALE; GENETIC DISTANCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MOLECULAR CLONING; MOLECULAR EVOLUTION; MONONUCLEAR CELL; NUCLEIC ACID BASE SUBSTITUTION; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; VIRION; VIRUS CULTURE; VIRUS REPLICATION;

EID: 0031060165     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.1.663-677.1997     Document Type: Article

References (94)

1. Ahmad, N., B. M. Baroudy, R. C. Baker, and C. Chappey. 1995. Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J. Virol. 69:1001-1012.
2. 1a.AIDS Clinical Trials Group Virology Technology Advisory Committee. 1994. ACTG virology manual for HIV laboratories. Division of AIDS, National Institute for Allergy and Infectious Diseases, Bethesda, Md.
3. Aldhous, M. C., K. C. Watret, J. V. Mok, A. G. Bird, and K. S. Forebel. 1994. Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection. Clin. Exp. Immunol. 97:61-67.
4. Alimenti, A., K. Luzuriaga, B. Stechenberg, and J. L. Sullivan. 1991. Quantitation of human immunodeficiency virus in vertically infected infants and children. J. Pediatr. 119:225-229.
5. Altschul, S. F., W. Gish, W. Miller, and E. W. Myers. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
6. Asjo, B., J. Albert, A. Karlsson, L. Morfeld-Manson, G. Biberfeld, K. Lidman, and E. M. Fenyo. 1986. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet ii:660-662.
7. Auger, I., P. Thomas, V. De Gruttola, D. Morse, D. Moore, R. Williams, B. Truman, and C. E. Lawrence. 1988. Incubation periods for paediatric AIDS patients. Nature 336:575-577.
8. Blanche, S., M.-J. Mayaux, C. Rouzioux, J.-P. Teslas, G. Firtion, F. Monpoux, N. Ciraru-Visneron, F. Meier, J. Tricoirs, O. Courpotin, E. Vilmer, C. Griscelli, J.-F. Delfraissy, and the French Pediatric HIV Infections Study Group. 1994. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N. Engl. J. Med. 330:308-312.
9. Bryson, Y., C. K. Luzuriaga, J. L. Sullivan, and D. W. Wara. 1992. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N. Engl. J. Med. 327:1246-1247.
10. Byers, B., B. Caldwell, and M. Oxtoby. 1993. Survival of children with perinatal HIV-1 infection: evidence for two distinct populations, p. 10-16. In Abstract Book of the 9th International Conference on AIDS, vol. 1.
11. Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:201-208.
12. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249-256.
13. Chesebro, B., K. Wehrly, J. Nichio, and S. Perryman. 1992. Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66:6547-0554.
14. Cheynier, R., P. Langlade-Demoyen, M. R. Marescot, S. Blanche, G. Blondin, S. Wain-Hobson, C. Griscelli, E. Vilmer, and F. Plata. 1992. Cytotoxic T-lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur. J. Immunol. 22:2211-2217.
15. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
16. Connor, R., H. Mohri, Y. Cao, and D. D. Ho. 1993. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1 infected individuals. J. Virol. 67:1772-1777.
17. Deacon, N. J., A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellett, C. Chatfield, V. A. Lawson, S. Crowe, A. Maetz, S. Sonza, J. Learmont, J. S. Sulivan, A. Cunningham, D. Dwyer, D. Dowton, and J. Mills. 1995. Genomic structure of an attenuated quasispecies of HIV-1 from a blood transfusion donor and recipients. Science 270:988-991.
18. De La Torre, J. C., E. Wimmer, and J. J. Holland. 1990. Very high frequency of reversion to guanidine resistance in clonal pools of guanidine-dependent type 1 poliovirus. J. Virol. 6-4:604-671.
19. Delwart, E. L., H. W. Sheppard, B. D. Walker, J. Goudsmit, and J. I. Mullins. 1994. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J. Virol. 68:6672-6683.
20. De Rossi, A., C. Giaquinto, L. Ometto, F. Mammano, C. Zanotto, D. Dunn, and L. Chieco-Bianchi. 1993. Replication and tropism of human immunodeficiency virus type 1 as predictors of disease outcome in infants with vertically acquired infection. J. Pediatr. 123:929-936.
21. De Wolf, F., M. Roos, J. M. Lange, J. T. Houweling, R. A. Coutinho, J. van der Noordaa, P. T. Schellekens, and J. Goudsmit. 1988. Decline in CD4+ cell numbers reflects increase in HIV-1 replication. AIDS Res. Hum. Retroviruses 4:433-440.
22. Dickover, R. E., M. Dillong, S. G. Gillette, A. Deveikis, M. Keller, S. Plaeger-Marshall, I. Chen, A. Diagne, E. R. Stiehm, and Y. Bryson. 1995. Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J. Infect. Dis. 170:1279-1284.
23. Dickover, R. E., E. M. Garratty, S. A. Herman, M. S. Sim, S. Plaeger, P. J. Boyer, M. Keller, A. Deveikis, E. R. Steihm, and Y. Bryson. 1996. Identification of levels of maternal HIV-1 RNA. associated with risk of perinatal transmission: effect of maternal zidovudine treatment on viral load. JAMA 278:566-605.
24. Duarte, E. A., I. S. Novella, S. Ledesma, D. K. Clarke, A. Moya, S. F. Elena, E. Domingo, and J. J. Holland. 1994. Subclonal components of consensus fitness in an RNA virus clone. J. Virol. 68:4295-4301.
25. Duliege, A. M., A. Messiah, S. Blanche, M. Tardieu, C. Griscelli, and A. Spira. 1992. Natural history of human immunodeficiency virus type 1 infection in children: prognostic value of laboratory tests on the bimodal progression of the disease. Pediatr. Infect. Dis. J. 11:630-635.
26. Eigen, M., and C. K. Biebriecker. 1988. Sequence space and quasispecies distribution, p. 211. In E. Domingo, J. J. Holland, and P. Ahlquist (ed.), RNA genetics, vol. 3. CRC Press, Inc., Boca Raton, Fla.
27. Faulkner, D. V., and A. Jurka. 1988. Multiple aligned sequence editor (MASE). Trends Biochem. Sci. 13:321-322.
28. Felsenstein, J. 1974. The evolutionary advantage of recombination. J. Genet. 78:737-756.
29. Felsenstein, J. 1988. Phylogenies from molecular sequences: inference and reliability. Annu. Rev. Genet. 22:521-565.
30. 28a.Felsenstein, J. 1993. PHYLIP (phylogeny inference package), version 3.5c. Department of Genetics, University of Washington, Seattle.
31. Fouchier, R. A. M., M. Groenick, N. A. Kootstra, M. Tersmette, H. G. Huisman, F. Miedema, and H. Schuitemaker. 1992. Phenotype-associated sequence variation in the third variable region of the human immunodeficiency virus type 1 molecule. J. Virol. 66:3183-3187.
32. + T-cell number decline in human immunodeficiency virus type 1-infected individuals. J. Virol. 69:2092-2100.
33. Galli, L., M. deMartino, P. A. Tovo, C. Gabiano, M. Zappa, C. Giaquinto, S. Tulisso, A. Vierucci, M. Guerra, P. Marchisio, A. Plebani, G. V. Zuccotti, A. M. Martino, P. Dallacasa, M. Stegagno, and the Italian Register for HIV Infection in Children. 1995. Onset of clinical signs in children with HIV-1 perinatal infection. AIDS 9:455-461.
34. Greenough, T. C., M. Somasuundaran, D. B. Brettler, R. H. Hesselton, A. Alimenti, G. Kirchhoff, D. Panicali, and J. L. Sullivan. 1994. Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 10:395-403.
35. Grubman, S., E. Gross, N. Lerner-Weiss, M. Hernandez, G. D. MeSherry, L. G. Hoyt, M. Boland, and J. M. Oleske. 1995. Older children and adolescents living with perinatally acquired human immunodeficiency virus infection. Pediatrics 95:657-663.
36. Henrard, D., M. Fauvel, J. Samson, G. Delage, M. Boucher, C. Hankins, J. Stephens, and N. Lapointe. 1993. Ontogeny of the humoral immune response to human immunodeficiency virus type 1 in infants. J. Infect. Dis. 168:288-291.
37. Hillis, D. M., and J. J. Bull. 1993. An empirical test of bootstrapping as a method for assessing confidence in phylogenetic analysis. Syst. Biol. 42:182-189.
38. Holland, J. J., J. C. La Torre, and D. A. Steinhauer. 1992. RNA virus populations as quasispecies. Curr. Top. Microbiol. Immunol. 176:1-20.
39. Holmes, E. C., L. Q. Zhang, P. Simmonds, C. A. Ludlam, and A. J. Leigh Brown. 1992. Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc. Natl. Acad. Sci. USA 89:4835-4839.
40. Italian Register for HIV Infection in Children. 1994. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 343:191-195.
41. Iversen, A. K. N., E. G. Shpaer, A. G. Rodrigo, M. S. Hirsch, B. D. Walker, H. W. Sheppard, T. C. Merigan, and J. I. Mullins. 1995. Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. J. Virol. 69:5743-5753.
42. Kirchhoff, F., T. C. Greenough, D. B. Brettler, J. L. Sullivan, and R. C. Desrosiers. 1995. Absence of intact net sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332:228-232.
43. Korber, B. T. M., G. Learn, J. I. Mullins, B. H. Hahn, and S. Wolinsky. 1995. Protecting HIV databases. Nature 378:242-243.
44. Korber, B. T. M., K. J. Kunstman, B. K. Patterson, M. Furtado, M. M. McEvilly, R. Levy, and S. M. Wolinsky. Genetic differences between blood-and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J. Virol. 68:7467-7481.
45. Korber, B. T. M., S. Wolinsky, B. Haynes, K. Kunstman, R. Levy, M. Furtado, P. Otto, and G. Meyers. 1992. HIV-1 intrapatient sequence diversity in the immunogenic V3 region. AIDS Res. Hum. Retroviruses 8:1461-1465.
46. Korber, B. T. M., R. M. Farber, D. H. Wolpert, and A. S. Lapedes. 1987. Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: an information theoretic analysis. Proc. Natl. Acad. Sci. USA 90:7176-7180.
47. Kuiken, C., J. Jong, E. Baan, W. Keulen, M. Tersmette, and J. Goudsmit. 1992. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. J. Virol. 66:4622-4627.
48. Kwok, S., and R. Higuchi. 1989. Avoiding false positives with PCR. Nature 339:237-238.
49. Lamers, S. L., J. W. Sleasman, J. X. She, K. A. Barrie, S. M. Pomeroy, D. J. Barrett, and M. M. Goodenow. 1994. Persistence of multiple maternal genotypes of human immunodeficiency virus type 1 in infants infected by vertical transmission. J. Clin. Invest. 93:380-390.
50. Ljunggren, K., V. Moschese, P. A. Broliden, C. Giaquinto, I. Quinti, E. M. Fenyo, B. Wahren, P. Rossi, and M. Jondal. 1990. Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers. J. Infect. Dis. 161:198-202.
51. Lukashov, V. V., C. A. Kuiken, and J. Goudsmit. 1995. Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. J. Virol. 69:6911-6916.
52. Luzuriaga, K., R. A. Koup, C. A. Pikora, D. B. Brettler, and J. L. Sullivan. 1991. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children. J. Pediatr. 119:230-236.
53. Luzuriaga, K., D. Holmes, A. Hereema, J. Wong, D. L. Panicali, and J. L. Sullivan. 1995. HIV-1-specific cytotoxic T-lymphocyte responses in the first year of life. J. Immunol. 154:433-443.
54. Mammano, F., F. Salvatori, L. Ometto, M. Panozzo, L. Chieco-Bianchi, and A. DeRossi. 1995. Relationship between the V3 loop and the phenotypes of human immunodeficiency type 1 (HIV-1) isolates from children perinatally infected with HIV-1. J. Virol. 69:82-92.
55. Marthas, M. L., K. K. A. Van Romay, M. Otsyula, C. J. Miller, D. R. Canfield, N. C. Pedersen, and M. B. McChesney. 1995. Viral factors determine progression to AIDS in simian immunodeficiency virus infected newborn rhesus macaques. J. Virol. 69:4198-4205.
56. McFarland, E. J., T. J. Curiel, D. J. Schoen, M. E. Rnsandich, R. T. Schooley, and D. R. Kurizkes. 1993. Cytotoxic T-lymphocyte lines specific for human immunodeficiency virus type 1 gag and reverse transcriptase derived from a vertically infected child. J. Infect. Dis. 167:719-723.
57. Michael, N. L., G. Chang, L. A. D'Arcy, C. J. Tseng, D. L. Birx, and H. W. Sheppard. 1945. Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression. J. Virol. 69:6758-6769.
58. Miedema, F., L. Meyaard, M. Koot, M. R. Klein, M. T. Roos, M. Groenink, R. A. Fouchier, A. B. Van't Wout, M. Tersmette, and P. T. Schellekens. 1944. Changing virus-host interactions in the course of HIV-1 infection. Immunol. Rev. 140:35-72.
59. Mulder-Kampinga, G. A., C. Kuiken, J. Dekker, H. J. Sherpbier, K. Boer, and J. Goudsmit. 1993. Genomic human immunodeficiency virus type 1 RNA variation in mother and child following intra-uterine virus transmission. J. Gen. Virol. 74:1747-1756.
60. Myers, G., B. T. M. Korber, J. A. Berzofsky, R. F. Smith, and G. N. Pavlakis. 1992. Human retroviruses and AIDS database 1992. Theoretical Biology, Los Alamos National Laboratory, Los Alamos, N.M.
61. Nei, M., and T. Gojobori. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3:418-426.
62. Neiburg, P., D. J. Hu, S. Moses, and N. Nagelkerke. 1995. Contribution of breastfeeding to the reported variation in rates of mother-to-child HIV transmission. AIDS 9:396-397.
63. Novella, I. S., S. F. Elena, A. Moya, E. Domingo, and J. J. Holland. 1995. Size of genetic bottlenecks leading to virus fitness loss is determined by mean initial population fitness. J. Virol. 69:2869-2872.
64. Nowak, M., R. M. Anderson, A. R. McLean, T. F. Wolfs, J. Goudsmit, and R. M. May. 1991. Antigenic diversity thresholds and the development of AIDS. Science 254:963-969.
65. Plaeger-Marshall, S., P. Hultin, J. Bertolli, S. O'Rourke, R. Kobayashi, A. L. Kobayashi, J. V. Giorgi, Y. Bryson, and E. R. Stiehm. 1993. Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children. J. Acquired Immune Defic. Syndr. 6:984-993.
66. Pollack, H., M. H. Zhan, T. Ilmet-Moore, K. Ajuang-Simbiri, K. Krasinski, and W. Borkowsky. 1993. Ontogeny of anti-human immunodeficiency virus (HIV) antibody production in HIV-1 infected infants. Proc. Natl. Acad. Sci. USA 90:2340-2344.
67. Richman, D., and S. Bozzette. 1994. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J. Infect. Dis. 169:968-974.
68. Safrit, J. T., C. A. Andrews, T. Zhu, D. D. Ho, and R. A. Koup. 1994. Characterization of human immunodeficiency virus typo 1-specific cytotoxic T lymphocyte clones isolated from acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J. Exp. Med. 179:463-472.
69. Schrager, L., J. Young, M. G. Fowler, B. Mathieson, and S. Vermund. 1994. Long-term survivors of HIV-1 infection: definitions and research challenges. AIDS 8(Suppl. 1):S95-S108.
70. Schuitemaker, H., N. Loostra, R. De Goede, F. Wolf, F. Miedema, and M. Tersmette. 1991. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J. Virol. 65:356-363.
71. Schuitemaker, H., M. Koot, N. Kootstra, M. Dercksen, R. De Goede, R. Steenwijk, J. Lange, J. E. Schattenkerk, F. Miedema, and M. Tersmette. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66:1354-1360.
72. Scott, G. B., C. Hutto, R. W. Makuch, M. T. Mastrucci, T. O'Connor, C. D. Mitchell, E. J. Trapido, and W. P. Parks. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N. Engl. J. Med. 321:1791-1796.
73. Scott, G. B., B. E. Buck, J. G. Leterman, F. L. Bloom, and W. P. Parks. 1984. Acquired immunodeficiency syndrome in infants. N. Engl. J. Med. 310:76-81.
74. Shioda, T., J. A. Levy, and C. Cheng-Mayer. 1991. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 349:167-169.
75. Simmonds, P., P. Balfe, C. A. Ludlam, J. O. Bishop, and A. J. Leigh-Brown. 1990. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J. Virol. 64:5840-5850.
76. Smith, R. F., and T. F. Smith. 1990. Automatic generation of primary sequence patterns from sets of related protein sequences. Proc. Natl. Acad. Sci. USA 87:118-122.
77. Smith, R. F., and T. F. Smith. 1992. Pattern-induced multisequence alignment (PIMA) algorithm employing secondary structure-dependant gap penalties for use in comparative protein modeling. Protein Eng. 5:35-41.
78. Spencer, T. L., M. T. Ogino, W. M. Dankner, and S. A. Spector. 1994. Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children. J. Infect. Dis. 169:491-495.
79. Spira, A. I., and D. D. Ho. 1995. Effect of different donor cells on human immunodeficiency virus type 1 replication and selection in vitro. J. Virol. 69:422-429.
80. Statistical Sciences. 1995. S-PLUS, version 3.3. StatSci, a division of Math-Soft, Inc., Seattle, Wash.
81. Strunnikova, N., S. C. Ray, R. A. Livingston, E. Rubalcaba, and R. P. Viscidi. 1995. Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression. J. Virol. 69:7548-7558.
82. Swofford, D. 1993. PAUP (phylogenetic analysis using parsimony) version 3.1. Center for Biodiversity, Illinois Natural History Survey, Champaign, Ill.
83. Tersmette, M., R. De Goede, B. Al, I. Winkel, R. Gruters, H. Cuypers, H. Huisman, and K. Miedema. 1988. Differential syncytiurn-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired, immunodeficiency virus syndrome (AIDS) and AIDS-related complex. J. Virol. 62:2026-2032.
84. Tersmette, M., R. A. Gruters, F. deWolf, R. E. Y. deGoede, J. M. A. Lange, P. T. A. Shellekens, J. Goudsmit, H. G. Huisman, and F. Miedema. 1989. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 63:2118-2125.
85. Tersmette, M., J. Lange, R. De Goede, F. Wolf, J. Eeftink-Shattenkerk, P. Shellekens, R. A. Coutinho, H. Huisman, J. Goudsmit, and F. Miedema. 1989. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet i:983-985.
86. Tovo, P. A., M. de Martina, C. Gabiano, L. Galli, C. Tibaldi, A. Vierucci, and F. Veglia. 1994. AIDS appearance in children is associated with the velocity of disease progression in their mothers. J. Infect. Dis. 170:1000-1002.
87. Tovo, P. A., M. De Martino, C. Gabiano, N. Cappelo, R. D'Elia, A. Loy, A. Plebani, G. V. Zuccotti, P. Dallacasa, G. Ferraris, D. Caselli, C. Fundaro, P. D'Argenio, L. Galli, N. Prinicipi, M. Stegagno, E. Ruga, E. Palomba, and the Italian Register for HIV Infection in Children. 1992. Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 229:1249-1253.
88. von Siedlein, L., E. Garratty, K. Dickover, and Y. J. Bryson. 1994. Lack of correlation of virus phenotype (syncytia-inducing) with onset and progression of disease in vertically HIV-1 infected infants. J. Cell. Biochem. Suppl. 18B:144.
89. Wade, A. M., A. E. Ades, D. T. Dunn, M. L. Newell, and C. S. Peckham. 1992. Age-related standards for T-lymphocyte subsets based on uninfected children born to human immunodeficiency virus 1-infected women. Pediatr. Infect. Dis. J. 11:1018-1026.
90. Walker, B. D., S. Chakrabarti, B. Moss, T. J. Paradis, T. Flynn, A. G. Durno, R. S. Blumberg, J. C. Kaplan, M. S. Hirsch, and R. T. Schooley. 1987. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345-348.
91. Willey, R. L., T. S. Theodore, and M. A. Martin. 1994. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 loop that chance viral tropism also alter physical and functional properties of the virion envelope. J. Virol. 68:4409-4419.
92. Wolfs, T. F. W., J. J. deJong, H. van den Berg, J. M. G. H. Tijnagel, W. J. A. Krone, and J. Goudsmit. 1990. Evolution of sequences encoding the principal neutralization epitope of HIV-1 is host-dependent, rapid and continuous. Proc. Natl. Acad. Sci. USA 87:9938-9942.
93. Wolinsky, S. M., C. Wike, B. T. M. Korber, C. Hutto, W. P. Parks, L. L. Rosenblum, K. J. Kunstman, M. R. Furtado, and J. L. Munoz. 1992. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 255:1134-1137.
94. Wolinsky, S. M., B. T. M. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, J. T. Safrit, and R. A. Koup. 1996. Adaptive evolution of human immunodeficiency virus type 1 during the natural course of infection. Science 272:537-542.